Indivior to Participate in Upcoming Investor Conferences
Get Alerts INDV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 22.7%
EPS Growth %: +11.1%
Join SI Premium – FREE
RICHMOND, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences:
- Barclays 28th Annual Global Healthcare Conference – Miami, FL
Joe Ciaffoni, Chief Executive Officer, will host 1x1 / group meetings on Tuesday, March 10th. Joe Ciaffoni will also participate in a fireside chat on Tuesday, March 10th at 2:00 p.m. U.S. EST. Interested investors should contact their Barclays representative to schedule a meeting. The fireside chat will be publicly available and can be accessed using the following weblink: Barclays Webcast Link.
- 2026 Jefferies Biotech on the Beach Summit – Miami, FL
Joe Ciaffoni, Chief Executive Officer, will host 1x1 / group meetings on Wednesday, March 11th. Interested investors should contact their Jefferies representative to schedule a meeting.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine — developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities, we are powering recovery and renewing hope. Visit https://www.indivior.com/ to learn more. Connect with Indivior on LinkedIn by visiting https://www.linkedin.com/company/indivior.
For Further Information
Investors:
Jason Thompson
Indivior Pharmaceuticals
Tel: 804-402-7123
E-mail: [email protected]
Media:
Cassie France-Kelly
Indivior Pharmaceuticals
Tel: 804-594-0836
E-Mail: [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Family-Owned Canadian Supplement Brand Herba Ranks No. 81 on The Globe and Mail’s List of Canada’s Top Growing Companies
- Golfing Queen Foundation Announces Prodigi as Title Sponsor for 2026 All Sports Reunion: Legends & Executives Golf Invitationall
- Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Jefferies & Co, BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share